Need more information, quote or place an order? Please email to: email@example.com
|EAG-2081a||Adrenal gland disease spectrum (adrenal gland cancer progression) tissue array (2017 WHO classification), including TNM and clinical stage (AJCC 7th edition), 96 cases/192 cores, replacing AD2081||96||192||682.50|
|T431||Adrenal gland tumor with adrenal gland tissue test array, 6 cases/24 cores||6||24||82.50|
|EN801a||Endocrine cancer tissue array, including TNM and clinical stage, 40 cases/80 cores, replacing EN801||40||80||382.50|
|T002||Endocrine organ tumor test tissue array, with normal control tissue, including TNM and clinical stage, 6 cases/24 cores||6||24||82.50|
|ENS2081||Endocrine system benign?malignant tumor and normal tissue array, including TNM and clinical stage, 104 cases/208 cores||104||208||682.50|
|TH802a||Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases/80 cores, replaced by TH802b||80||80||337.50|
|TH801a||Thyroid cancer and thyroid gland tissue array, including pathology grade, TNM and clinical stage, 74 cases/80 cores, replacing TH801||74||80||337.50|
|TH801b||Thyroid cancer and thyroid gland tissue array, including pathology grade, TNM and clinical stage, 74 cases/80 cores, replacing TH801a||74||80||382.50|
|TH809||Thyroid cancer metastasis tissue array, 40 cases/80 cores, replaced by TH809a||40||80||382.50|
|TH809b||Thyroid cancer metastasis tissue array, 40 cases/80 cores, replaced TH809a||40||80||382.50|
|T152||Thyroid cancer tissue array, including TNM and pathology grade, 6 cases/24 cores||6||24||82.50|
|TH242||Thyroid cancer with matched cancer adjacent thyroid tissue array, including TNM and clinical stage, 12 cases/24 cores, replacing THC241||12||24||60.00|
|TH241||Thyroid cancer with matched cancer adjacent thyroid tissue array, including TNM andclinical stage, 10 cases/24 cores||10||24||82.50|
|T151||Thyroid cancer with thyroid tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores||6||24||82.50|
|T153b||Thyroid gland tumor test tissue with normal tissue array, including TNM and clinical satge, 6 cases/24 cores, replacing T153a||6||24||82.50|
|THT501 (THY501)||Thyroid gland tumor with thyroid gland tissue array (2017 WHO classification), including pathology grade, TNM and clinical satge (AJCC 7th edition), 50 cases/50 cores||50||50||202.50|
|THN241a||Normal thyroid gland tissue array, 24 cases/24 cores, replacing THN241||24||24||247.50|
|TH8010b(TH8010a)||Different stage of thyroid gland cancer array with normal thyroid gland tissue, including TNM and clinical stage, 80 cases/80 cores, replacing TH8010a||80||80||382.50|
Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH)
1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
T – Primary tumor
Tx – Primary tumor cannot be assessed
T0 – No evidence of primary tumor
Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 – Tumor invades submucosa
T2 – Tumor invades muscularis propria
T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum
N – Regional lymph nodes
Nx – Regional lymph nodes cannot be assessed
N0 – No regional lymph node metastasis
N1 – Metastasis in 1 to 3 regional lymph nodes
N2 – Metastasis in 4 or more regional lymph nodes
M – Distant metastasis
Mx – Distant metastasis cannot be assessed
M0 – No distant metastasis
M1 – Distant metastasis
Stage of Cancer
- Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
- Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
- Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
- Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.